DK0662948T3 - 2-amino-4-phenyl-4-oxosmørsyrederivater med kynureninase- og/eller kynurenin-3-hydroxylaseinhiberende virkning - Google Patents
2-amino-4-phenyl-4-oxosmørsyrederivater med kynureninase- og/eller kynurenin-3-hydroxylaseinhiberende virkningInfo
- Publication number
- DK0662948T3 DK0662948T3 DK94921642T DK94921642T DK0662948T3 DK 0662948 T3 DK0662948 T3 DK 0662948T3 DK 94921642 T DK94921642 T DK 94921642T DK 94921642 T DK94921642 T DK 94921642T DK 0662948 T3 DK0662948 T3 DK 0662948T3
- Authority
- DK
- Denmark
- Prior art keywords
- kynurenine
- oxo
- phenyl
- amino
- kynureninase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT93MI001649A IT1265101B1 (it) | 1993-07-23 | 1993-07-23 | Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico |
PCT/EP1994/002280 WO1995003271A1 (en) | 1993-07-23 | 1994-07-12 | 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0662948T3 true DK0662948T3 (da) | 1999-06-21 |
Family
ID=11366678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94921642T DK0662948T3 (da) | 1993-07-23 | 1994-07-12 | 2-amino-4-phenyl-4-oxosmørsyrederivater med kynureninase- og/eller kynurenin-3-hydroxylaseinhiberende virkning |
Country Status (21)
Country | Link |
---|---|
US (1) | US20010008947A1 (pt) |
EP (1) | EP0662948B1 (pt) |
JP (1) | JPH08501805A (pt) |
KR (1) | KR950703517A (pt) |
CN (1) | CN1112786A (pt) |
AT (1) | ATE171935T1 (pt) |
AU (1) | AU678273B2 (pt) |
CA (1) | CA2144521A1 (pt) |
DE (1) | DE69413789T2 (pt) |
DK (1) | DK0662948T3 (pt) |
ES (1) | ES2123801T3 (pt) |
FI (1) | FI951298A (pt) |
HU (1) | HUT70478A (pt) |
IL (1) | IL110365A (pt) |
IT (1) | IT1265101B1 (pt) |
NZ (1) | NZ268896A (pt) |
PL (1) | PL179857B1 (pt) |
RU (1) | RU2139850C1 (pt) |
TW (1) | TW268937B (pt) |
WO (1) | WO1995003271A1 (pt) |
ZA (1) | ZA945425B (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5519055A (en) * | 1993-08-06 | 1996-05-21 | University Of Maryland At Baltimore | Substituted kynurenines and process for their preparation |
US5786508A (en) * | 1994-07-15 | 1998-07-28 | Pharmacia & Upjohn S.P.A. | Substituted kynurenines and process for their preparation |
GB9521486D0 (en) * | 1995-10-20 | 1995-12-20 | Pharmacia Spa | Fluoro-substituted benzoylpropionic acid derivatives |
GB9615441D0 (en) * | 1996-07-23 | 1996-09-04 | Pharmacia Spa | Benzoylpropionic acid ester derivatives |
WO1998006711A1 (en) * | 1996-08-16 | 1998-02-19 | Warner-Lambert Company | Butyric acid matrix metalloproteinase inhibitors |
GB9618349D0 (en) * | 1996-09-03 | 1996-10-16 | Pharmacia Spa | N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
GB9716103D0 (en) * | 1997-07-30 | 1997-10-01 | Pharmacia & Upjohn Spa | Condensed heterocyclic compounds |
GB9725055D0 (en) * | 1997-11-26 | 1998-01-28 | Pharmacia & Upjohn Spa | 1,3,4-thiadiazoles compounds |
GB9725141D0 (en) * | 1997-11-27 | 1998-01-28 | Pharmacia & Upjohn Spa | Benzenesulfonamide compounds |
AU757925B2 (en) * | 1998-02-23 | 2003-03-13 | New York University | Indole-3-propionic acids, salts and esters thereof used as medicaments |
US6783965B1 (en) * | 2000-02-10 | 2004-08-31 | Mountain View Pharmaceuticals, Inc. | Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
ES2644413T3 (es) * | 1998-11-11 | 2017-11-28 | Novartis Ag | Producción de 2-amino-2-[2-(4-alquil-fenil)etil]propano-1,3-dioles |
CN1144779C (zh) * | 1999-03-11 | 2004-04-07 | 杭州中美华东制药有限公司 | 制备2-[2-(4-烷基苯基)-乙基]-2-氨基-丙二醇的方法以及其中制得的中间产物 |
US7101910B2 (en) * | 2001-06-12 | 2006-09-05 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
FR2827045B1 (fr) | 2001-07-05 | 2007-08-10 | Univ Pasteur | Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments |
FR2827859B1 (fr) | 2001-07-30 | 2005-09-23 | Lipha | Derives 4-(arylthio) - ou 4-(heteroarylthio) -butyrique dans la preparation de medicaments destines au traitement du diabete |
CN1330774C (zh) * | 2002-03-01 | 2007-08-08 | 国家人类基因组南方研究中心 | 犬尿氨酸水解酶多态性及其用途 |
ITMI20041626A1 (it) * | 2004-08-06 | 2004-11-06 | Roberto Pellicciari | Inibitori della chinurenina-ammino-trasferasi |
CN1309702C (zh) * | 2005-10-28 | 2007-04-11 | 中国科学院上海有机化学研究所 | 犬尿氨酸酶的特异性抑制剂l-邻甲氧基苯甲酰基丙氨酸的合成方法 |
AU2009226975B2 (en) * | 2008-03-19 | 2012-09-06 | Novartis Ag | Process for the preparation of 2-amino-2- [2- (4-C3-C21-alkyl-phenyl)ethyl] propane-1, 3-diols |
EP3197466B1 (en) * | 2014-09-26 | 2021-02-17 | The University Of British Columbia | A combination of kynurenine and antigen presenting cells (apc) as therapeutics and methods for their use in immune modulation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0501378B1 (en) * | 1991-02-28 | 1995-01-11 | Merrell Dow Pharmaceuticals Inc. | NMDA Antagonists |
EP0581907A1 (en) * | 1991-04-18 | 1994-02-09 | The University Of Georgia Research Foundation, Inc. | Inhibitors of kynureninase |
US5495044A (en) * | 1991-04-18 | 1996-02-27 | University Of Georgia Research Foundation, Inc. | Inhibitors of kynureninase |
GB9325360D0 (en) * | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
-
1993
- 1993-07-23 IT IT93MI001649A patent/IT1265101B1/it active IP Right Grant
-
1994
- 1994-07-12 DE DE69413789T patent/DE69413789T2/de not_active Expired - Fee Related
- 1994-07-12 AT AT94921642T patent/ATE171935T1/de not_active IP Right Cessation
- 1994-07-12 DK DK94921642T patent/DK0662948T3/da active
- 1994-07-12 ES ES94921642T patent/ES2123801T3/es not_active Expired - Lifetime
- 1994-07-12 KR KR1019950701103A patent/KR950703517A/ko active IP Right Grant
- 1994-07-12 JP JP7503289A patent/JPH08501805A/ja active Pending
- 1994-07-12 CN CN94190531A patent/CN1112786A/zh active Pending
- 1994-07-12 HU HU9501146A patent/HUT70478A/hu unknown
- 1994-07-12 RU RU95111308A patent/RU2139850C1/ru active
- 1994-07-12 PL PL94308142A patent/PL179857B1/pl unknown
- 1994-07-12 CA CA002144521A patent/CA2144521A1/en not_active Abandoned
- 1994-07-12 EP EP94921642A patent/EP0662948B1/en not_active Expired - Lifetime
- 1994-07-12 NZ NZ268896A patent/NZ268896A/en unknown
- 1994-07-12 AU AU72285/94A patent/AU678273B2/en not_active Ceased
- 1994-07-12 WO PCT/EP1994/002280 patent/WO1995003271A1/en active IP Right Grant
- 1994-07-19 IL IL110365A patent/IL110365A/en not_active IP Right Cessation
- 1994-07-21 TW TW083106674A patent/TW268937B/zh active
- 1994-07-22 ZA ZA945425A patent/ZA945425B/xx unknown
-
1995
- 1995-03-20 FI FI951298A patent/FI951298A/fi unknown
-
1997
- 1997-10-14 US US08/949,392 patent/US20010008947A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0662948A1 (en) | 1995-07-19 |
FI951298A0 (fi) | 1995-03-20 |
RU95111308A (ru) | 1996-12-27 |
US20010008947A1 (en) | 2001-07-19 |
AU7228594A (en) | 1995-02-20 |
PL179857B1 (pl) | 2000-11-30 |
CN1112786A (zh) | 1995-11-29 |
ZA945425B (en) | 1995-03-01 |
JPH08501805A (ja) | 1996-02-27 |
DE69413789T2 (de) | 1999-05-06 |
NZ268896A (en) | 1997-01-29 |
WO1995003271A1 (en) | 1995-02-02 |
CA2144521A1 (en) | 1995-02-02 |
TW268937B (pt) | 1996-01-21 |
PL308142A1 (en) | 1995-07-24 |
DE69413789D1 (de) | 1998-11-12 |
ES2123801T3 (es) | 1999-01-16 |
IL110365A0 (en) | 1994-10-21 |
ATE171935T1 (de) | 1998-10-15 |
IL110365A (en) | 1998-06-15 |
ITMI931649A0 (it) | 1993-07-23 |
FI951298A (fi) | 1995-03-20 |
HUT70478A (en) | 1995-10-30 |
EP0662948B1 (en) | 1998-10-07 |
KR950703517A (ko) | 1995-09-20 |
HU9501146D0 (en) | 1995-06-28 |
RU2139850C1 (ru) | 1999-10-20 |
IT1265101B1 (it) | 1996-10-30 |
ITMI931649A1 (it) | 1995-01-23 |
AU678273B2 (en) | 1997-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0662948T3 (da) | 2-amino-4-phenyl-4-oxosmørsyrederivater med kynureninase- og/eller kynurenin-3-hydroxylaseinhiberende virkning | |
NO961326D0 (no) | Inhibitorer av | |
DK1465626T3 (da) | Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf | |
EP0374440A3 (en) | Inhibitors of lysyl oxidase | |
BG101841A (en) | Cellular adhesion inhibitors | |
EP1449834A3 (en) | Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas | |
JO2373B1 (en) | W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors | |
BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
BG102106A (en) | Phermaceutical composition containing proteinase inhibitor and monoglyceride | |
FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
DK1032556T3 (da) | Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
BG105763A (en) | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |